Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-18.82%Return on Assets
VS
Market
Sector
Industry
History
$ 3.04Close
$ 0.42 - $ 4.74 52-Week Range
Ticker Information
Ticker
ABVCCompany Name
ABVC BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQABVC BIOPHARMA INC - Return on Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ABVC - ROA Historical data
| Date | Total Assets | Net Income Common Stock | Return on Assets |
|---|---|---|---|
| 6/30/2025 | $ 16.24M | $ -3.06M | -18.82% |
| 3/31/2025 | $ 14.88M | $ -1.81M | -12.18% |
| 12/31/2024 | $ 7.54M | $ -4.9M | -65.03% |
| 9/30/2024 | $ 14.46M | $ -8.24M | -57% |
| 6/30/2024 | $ 14.63M | $ -11.37M | -77.73% |
| 3/31/2024 | $ 14.46M | $ -12.62M | -87.31% |
| 12/31/2023 | $ 14.49M | $ -10.52M | -72.56% |
| 9/30/2023 | $ 16.59M | $ -12.27M | -73.95% |
| 6/30/2023 | $ 9.32M | $ -12.66M | -135.79% |
| 3/31/2023 | $ 10.73M | $ -12.25M | -114.13% |
Key Performance Insights, Last 5 Years
- ABVC BIOPHARMA INC's latest trailing twelve months (TTM) ROA stands at 0%.
- Over the past 5 years, ABVC BIOPHARMA INC's average ROA has been -95.68%.
- The median ROA for ABVC BIOPHARMA INC during this period was -87.31%
- ABVC BIOPHARMA INC reached its highest ROA over the past 5 years at -12.18%.
- The lowest ROA recorded by ABVC BIOPHARMA INC in the same timeframe -185.98%
ABVC BIOPHARMA INC's ROA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROA Benchmarks
Similar metrics to ROA:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Equity - [Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
Definition of Return on Assets
[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.Net Inc. Cmn. / Assets
(=) ROA ROA for ABVC BIOPHARMA INC is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Assets [ $ 10.53M ]
(=) ROA [ 0% ] ABVC - Return on Assets, Last 5 years
-185.98%
Minimum
Sep 30, 2022
-12.18%
Maximum
Mar 31, 2025
-95.68%
Average
-87.31%
Median
ROA Benchmark AnalysisMarket
The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.12% with a standard deviation of 10.61%.
The following table provides additional summary stats:
ROA in the Market:
| filtered constituents | 3.44K |
|---|---|
| min | -33.4% |
| max | 33.98% |
| average | 0.12% |
| median | 1.53% |
| std | 10.61% |